Bharat Rasayan Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 18, 2025, 12:49 am

Market Cap	4,712 Cr.
Current Price	11,320
High / Low	14,284/8,798
Stock P/E	33.4
Book Value	2,719
Dividend Yield	0.01 %
ROCE	16.6 %
ROE	13.3 %
Face Value	10.0
PEG Ratio	-13.15

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Bharat Rasayan Ltd

Competitors of Bharat Rasayan Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Epigral Ltd	7,512 Cr.	1,741	2,408/1,387	21.3	441	0.34 %	24.9 %	22.3 %	10.0
Dharmaj Crop Guard Ltd	1,149 Cr.	340	390/165	33.0	117	0.00 %	12.0 %	9.24 %	10.0
Bhaskar Agrochemicals Ltd	57.4 Cr.	110	148/55.2	14.7	34.1	0.00 %	21.3 %	24.7 %	10.0
Bhagiradha Chemicals & Industries Ltd	3,958 Cr.	305	448/254	145	53.9	0.05 %	7.44 %	4.91 %	1.00
Best Agrolife Ltd	969 Cr.	410	704/244	13.9	320	0.72 %	12.9 %	9.95 %	10.0
Industry Average	12,625.75 Cr	1,769.04		39.63	435.34	0.36%	15.27%	19.91%	7.25

All Competitor Stocks of Bharat Rasayan Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	445	327	292	309	306	239	263	233	310	282	328	256	307
Expenses	359	276	256	260	249	234	250	207	240	244	281	215	270
Operating Profit	86	51	36	49	56	6	13	26	69	38	47	42	37
OPM %	19%	16%	12%	16%	18%	2%	5%	11%	22%	14%	14%	16%	12%
Other Income	7	8	3	6	-3	9	4	4	22	22	7	18	6
Interest	3	2	1	2	1	0	1	1	1	1	1	1	1
Depreciation	7	6	7	7	6	6	6	7	6	6	6	7	7
Profit before tax	83	51	31	46	46	8	10	22	84	53	46	52	35
Tax %	23%	26%	26%	27%	34%	8%	39%	29%	20%	19%	30%	21%	27%
Net Profit	65	38	23	34	30	7	6	15	67	43	32	41	25
EPS in Rs	155.34	90.63	55.18	81.27	72.80	17.06	14.44	36.84	161.50	103.77	77.35	97.54	60.48

Last Updated: May 31, 2025, 9:38 am

Below is a detailed analysis of the quarterly data for Bharat Rasayan Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 307.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Dec 2024) to 307.00 Cr., marking an increase of 51.00 Cr..
For Expenses, as of Mar 2025, the value is 270.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 215.00 Cr. (Dec 2024) to 270.00 Cr., marking an increase of 55.00 Cr..
For Operating Profit, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Dec 2024) to 37.00 Cr., marking a decrease of 5.00 Cr..
For OPM %, as of Mar 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Dec 2024) to 12.00%, marking a decrease of 4.00%.
For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 12.00 Cr..
For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 7.00 Cr..
For Profit before tax, as of Mar 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 52.00 Cr. (Dec 2024) to 35.00 Cr., marking a decrease of 17.00 Cr..
For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Dec 2024) to 27.00%, marking an increase of 6.00%.
For Net Profit, as of Mar 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Dec 2024) to 25.00 Cr., marking a decrease of 16.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 60.48. The value appears to be declining and may need further review. It has decreased from 97.54 (Dec 2024) to 60.48, marking a decrease of 37.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:56 pm

Metric	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	989	1,213	1,091	1,301	1,234	1,044	1,173
Expenses	802	983	852	1,050	1,043	926	998
Operating Profit	188	230	240	250	191	118	175
OPM %	19%	19%	22%	19%	15%	11%	15%
Other Income	1	14	6	16	15	35	42
Interest	16	16	4	7	6	3	5
Depreciation	17	22	26	25	26	26	27
Profit before tax	155	205	215	234	174	123	185
Tax %	28%	23%	24%	25%	28%	23%	24%
Net Profit	112	158	164	176	125	96	141
EPS in Rs	262.48	371.03	385.69	423.51	299.88	229.85	339.13
Dividend Payout %	1%	0%	0%	0%	0%	1%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	41.07%	3.80%	7.32%	-28.98%	-23.20%	46.88%
Change in YoY Net Profit Growth (%)	0.00%	-37.27%	3.52%	-36.29%	5.78%	70.08%

Bharat Rasayan Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	-1%
3 Years:	-3%
TTM:	12%

Compounded Profit Growth
10 Years:	%
5 Years:	-3%
3 Years:	-7%
TTM:	50%

Stock Price CAGR
10 Years:	25%
5 Years:	3%
3 Years:	-3%
1 Year:	5%

Return on Equity
10 Years:	%
5 Years:	17%
3 Years:	13%
Last Year:	13%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:22 pm

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4	4	4	4	4	4	4
Reserves	405	560	723	766	889	984	1,126
Borrowings	247	94	58	174	28	80	85
Other Liabilities	100	94	122	142	152	129	193
Total Liabilities	756	752	908	1,086	1,074	1,197	1,408
Fixed Assets	150	203	191	228	225	230	230
CWIP	35	18	18	11	11	6	15
Investments	0	9	150	43	67	143	298
Other Assets	570	522	549	803	771	818	865
Total Assets	756	752	908	1,086	1,074	1,197	1,408

Below is a detailed analysis of the balance sheet data for Bharat Rasayan Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
For Reserves, as of Mar 2025, the value is 1,126.00 Cr.. The value appears strong and on an upward trend. It has increased from 984.00 Cr. (Mar 2024) to 1,126.00 Cr., marking an increase of 142.00 Cr..
For Borrowings, as of Mar 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 80.00 Cr. (Mar 2024) to 85.00 Cr., marking an increase of 5.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 129.00 Cr. (Mar 2024) to 193.00 Cr., marking an increase of 64.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 1,408.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,197.00 Cr. (Mar 2024) to 1,408.00 Cr., marking an increase of 211.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 230.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 230.00 Cr..
For CWIP, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 9.00 Cr..
For Investments, as of Mar 2025, the value is 298.00 Cr.. The value appears strong and on an upward trend. It has increased from 143.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 155.00 Cr..
For Other Assets, as of Mar 2025, the value is 865.00 Cr.. The value appears strong and on an upward trend. It has increased from 818.00 Cr. (Mar 2024) to 865.00 Cr., marking an increase of 47.00 Cr..
For Total Assets, as of Mar 2025, the value is 1,408.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,197.00 Cr. (Mar 2024) to 1,408.00 Cr., marking an increase of 211.00 Cr..

Notably, the Reserves (1,126.00 Cr.) exceed the Borrowings (85.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	-52	263	170	-65	213	41	172
Cash from Investing Activity +	-46	-53	-149	64	-43	-76	-157
Cash from Financing Activity +	102	-169	-40	-25	-152	49	-1
Net Cash Flow	4	40	-19	-26	18	14	14

Free Cash Flow

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-59.00	136.00	182.00	76.00	163.00	38.00	90.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	103	75	99	130	96	138
Inventory Days	112	70	90	120	141	135
Days Payable	24	17	33	30	33	37
Cash Conversion Cycle	191	128	156	221	204	236
Working Capital Days	173	116	134	185	173	227
ROCE %		34%	31%	28%	20%	13%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%
FIIs	0.00%	0.00%	0.53%	0.39%	0.34%	0.35%	0.35%	0.34%	0.34%	0.35%	0.46%	0.45%
DIIs	2.84%	2.89%	2.57%	2.60%	2.57%	2.57%	2.57%	2.57%	2.57%	2.59%	2.64%	2.60%
Public	22.17%	22.11%	21.91%	22.02%	22.10%	22.09%	22.09%	22.09%	22.09%	22.07%	21.90%	21.96%
No. of Shareholders	16,747	17,384	16,375	17,304	17,234	16,361	16,059	15,398	14,667	15,156	15,889	15,857

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
PGIM India Midcap Opportunities Fund	63,964	0.58	57.67	63,964	2025-04-22 17:25:40	0%
PGIM India Small Cap Fund	26,931	1.66	24.28	26,931	2025-04-22 15:57:00	0%
Quant Small Cap Fund	16,063	0.09	14.48	16,063	2025-04-22 17:25:40	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	229.86	299.89	423.52	385.70	371.03
Diluted EPS (Rs.)	229.86	299.89	423.52	385.70	371.03
Cash EPS (Rs.)	258.47	377.50	486.31	447.73	422.68
Book Value[Excl.RevalReserv]/Share (Rs.)	2377.47	2149.86	1853.14	1711.78	1327.74
Book Value[Incl.RevalReserv]/Share (Rs.)	2377.47	2149.86	1853.14	1711.78	1327.74
Revenue From Operations / Share (Rs.)	2514.03	2970.60	3131.39	2570.20	2859.82
PBDIT / Share (Rs.)	332.52	521.37	651.03	580.53	578.93
PBIT / Share (Rs.)	270.46	458.73	591.01	519.90	527.29
PBT / Share (Rs.)	263.33	433.75	565.14	508.26	482.96
Net Profit / Share (Rs.)	196.40	314.86	426.29	387.10	371.04
NP After MI And SOA / Share (Rs.)	229.86	299.89	423.53	385.70	371.04
PBDIT Margin (%)	13.22	17.55	20.79	22.58	20.24
PBIT Margin (%)	10.75	15.44	18.87	20.22	18.43
PBT Margin (%)	10.47	14.60	18.04	19.77	16.88
Net Profit Margin (%)	7.81	10.59	13.61	15.06	12.97
NP After MI And SOA Margin (%)	9.14	10.09	13.52	15.00	12.97
Return on Networth / Equity (%)	9.66	13.94	22.85	22.53	27.94
Return on Capital Employeed (%)	11.23	21.10	31.43	29.94	37.43
Return On Assets (%)	7.97	11.60	16.14	18.04	20.96
Long Term Debt / Equity (X)	0.00	0.00	0.00	0.00	0.03
Total Debt / Equity (X)	0.08	0.03	0.22	0.08	0.16
Asset Turnover Ratio (%)	0.91	1.14	1.30	1.32	1.61
Current Ratio (X)	4.60	4.64	2.59	3.82	3.38
Quick Ratio (X)	3.25	2.74	1.70	2.83	2.33
Inventory Turnover Ratio (X)	2.30	2.85	4.16	4.04	4.26
Dividend Payout Ratio (NP) (%)	0.00	0.50	0.00	0.38	0.40
Dividend Payout Ratio (CP) (%)	0.00	0.41	0.00	0.33	0.35
Earning Retention Ratio (%)	0.00	99.50	0.00	99.62	99.60
Cash Earning Retention Ratio (%)	0.00	99.59	0.00	99.67	99.65
Interest Coverage Ratio (X)	46.68	37.31	39.68	67.02	15.75
Interest Coverage Ratio (Post Tax) (X)	28.57	24.32	27.56	46.03	11.30
Enterprise Value (Cr.)	3562.69	3772.42	5228.04	4021.85	2256.45
EV / Net Operating Revenue (X)	3.41	3.06	4.02	3.68	1.86
EV / EBITDA (X)	25.78	17.41	19.33	16.31	9.17
MarketCap / Net Operating Revenue (X)	3.38	3.06	3.89	3.66	1.82
Retention Ratios (%)	0.00	99.49	0.00	99.61	99.59
Price / BV (X)	3.57	4.23	6.57	5.49	3.92
Price / Net Operating Revenue (X)	3.38	3.06	3.89	3.66	1.82
EarningsYield	0.02	0.03	0.03	0.04	0.07

After reviewing the key financial ratios for Bharat Rasayan Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 229.86. This value is within the healthy range. It has decreased from 299.89 (Mar 23) to 229.86, marking a decrease of 70.03.
For Diluted EPS (Rs.), as of Mar 24, the value is 229.86. This value is within the healthy range. It has decreased from 299.89 (Mar 23) to 229.86, marking a decrease of 70.03.
For Cash EPS (Rs.), as of Mar 24, the value is 258.47. This value is within the healthy range. It has decreased from 377.50 (Mar 23) to 258.47, marking a decrease of 119.03.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 2,377.47. It has increased from 2,149.86 (Mar 23) to 2,377.47, marking an increase of 227.61.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 2,377.47. It has increased from 2,149.86 (Mar 23) to 2,377.47, marking an increase of 227.61.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 2,514.03. It has decreased from 2,970.60 (Mar 23) to 2,514.03, marking a decrease of 456.57.
For PBDIT / Share (Rs.), as of Mar 24, the value is 332.52. This value is within the healthy range. It has decreased from 521.37 (Mar 23) to 332.52, marking a decrease of 188.85.
For PBIT / Share (Rs.), as of Mar 24, the value is 270.46. This value is within the healthy range. It has decreased from 458.73 (Mar 23) to 270.46, marking a decrease of 188.27.
For PBT / Share (Rs.), as of Mar 24, the value is 263.33. This value is within the healthy range. It has decreased from 433.75 (Mar 23) to 263.33, marking a decrease of 170.42.
For Net Profit / Share (Rs.), as of Mar 24, the value is 196.40. This value is within the healthy range. It has decreased from 314.86 (Mar 23) to 196.40, marking a decrease of 118.46.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 229.86. This value is within the healthy range. It has decreased from 299.89 (Mar 23) to 229.86, marking a decrease of 70.03.
For PBDIT Margin (%), as of Mar 24, the value is 13.22. This value is within the healthy range. It has decreased from 17.55 (Mar 23) to 13.22, marking a decrease of 4.33.
For PBIT Margin (%), as of Mar 24, the value is 10.75. This value is within the healthy range. It has decreased from 15.44 (Mar 23) to 10.75, marking a decrease of 4.69.
For PBT Margin (%), as of Mar 24, the value is 10.47. This value is within the healthy range. It has decreased from 14.60 (Mar 23) to 10.47, marking a decrease of 4.13.
For Net Profit Margin (%), as of Mar 24, the value is 7.81. This value is within the healthy range. It has decreased from 10.59 (Mar 23) to 7.81, marking a decrease of 2.78.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.14. This value is within the healthy range. It has decreased from 10.09 (Mar 23) to 9.14, marking a decrease of 0.95.
For Return on Networth / Equity (%), as of Mar 24, the value is 9.66. This value is below the healthy minimum of 15. It has decreased from 13.94 (Mar 23) to 9.66, marking a decrease of 4.28.
For Return on Capital Employeed (%), as of Mar 24, the value is 11.23. This value is within the healthy range. It has decreased from 21.10 (Mar 23) to 11.23, marking a decrease of 9.87.
For Return On Assets (%), as of Mar 24, the value is 7.97. This value is within the healthy range. It has decreased from 11.60 (Mar 23) to 7.97, marking a decrease of 3.63.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Total Debt / Equity (X), as of Mar 24, the value is 0.08. This value is within the healthy range. It has increased from 0.03 (Mar 23) to 0.08, marking an increase of 0.05.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.91. It has decreased from 1.14 (Mar 23) to 0.91, marking a decrease of 0.23.
For Current Ratio (X), as of Mar 24, the value is 4.60. This value exceeds the healthy maximum of 3. It has decreased from 4.64 (Mar 23) to 4.60, marking a decrease of 0.04.
For Quick Ratio (X), as of Mar 24, the value is 3.25. This value exceeds the healthy maximum of 2. It has increased from 2.74 (Mar 23) to 3.25, marking an increase of 0.51.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.30. This value is below the healthy minimum of 4. It has decreased from 2.85 (Mar 23) to 2.30, marking a decrease of 0.55.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.50 (Mar 23) to 0.00, marking a decrease of 0.50.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.41 (Mar 23) to 0.00, marking a decrease of 0.41.
For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.50 (Mar 23) to 0.00, marking a decrease of 99.50.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.59 (Mar 23) to 0.00, marking a decrease of 99.59.
For Interest Coverage Ratio (X), as of Mar 24, the value is 46.68. This value is within the healthy range. It has increased from 37.31 (Mar 23) to 46.68, marking an increase of 9.37.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 28.57. This value is within the healthy range. It has increased from 24.32 (Mar 23) to 28.57, marking an increase of 4.25.
For Enterprise Value (Cr.), as of Mar 24, the value is 3,562.69. It has decreased from 3,772.42 (Mar 23) to 3,562.69, marking a decrease of 209.73.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.41. This value exceeds the healthy maximum of 3. It has increased from 3.06 (Mar 23) to 3.41, marking an increase of 0.35.
For EV / EBITDA (X), as of Mar 24, the value is 25.78. This value exceeds the healthy maximum of 15. It has increased from 17.41 (Mar 23) to 25.78, marking an increase of 8.37.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.38. This value exceeds the healthy maximum of 3. It has increased from 3.06 (Mar 23) to 3.38, marking an increase of 0.32.
For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.49 (Mar 23) to 0.00, marking a decrease of 99.49.
For Price / BV (X), as of Mar 24, the value is 3.57. This value exceeds the healthy maximum of 3. It has decreased from 4.23 (Mar 23) to 3.57, marking a decrease of 0.66.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.38. This value exceeds the healthy maximum of 3. It has increased from 3.06 (Mar 23) to 3.38, marking an increase of 0.32.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Bharat Rasayan Ltd as of July 18, 2025 is: 9,663.64

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of July 18, 2025, Bharat Rasayan Ltd is Overvalued by 14.63% compared to the current share price 11,320.00

Intrinsic Value of Bharat Rasayan Ltd as of July 18, 2025 is: 9,418.17

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of July 18, 2025, Bharat Rasayan Ltd is Overvalued by 16.80% compared to the current share price 11,320.00

Last 5 Year EPS CAGR: -2.54%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 21.00%, which is a positive sign. The company has higher reserves (779.00 cr) compared to borrowings (109.43 cr), indicating strong financial stability. The company has shown consistent growth in sales (142.14 cr) and profit (184.43 cr) over the years.	The stock has a high average Working Capital Days of 168.00, which may not be favorable. The stock has a high average Cash Conversion Cycle of 189.33, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bharat Rasayan Ltd:
1. Net Profit Margin: 7.81%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 11.23% (Industry Average ROCE: 15.27%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 9.66% (Industry Average ROE: 19.91%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 28.57
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 3.25
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 33.4 (Industry average Stock P/E: 39.63)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.08
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Bharat Rasayan Ltd. is a Public Limited Listed company incorporated on 15/05/1989 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L24119DL1989PLC036264 and registration number is 036264. Currently Company is involved in the business activities of Manufacture of various other chemical products(antiknock preparations, anti-freeze preparations, liquids for hydraulic transmission, composite diagnostic or laboratory reagents, writing or drawing ink, chemical substance used in manufacturing of pesticides and other chemical products). Company's Total Operating Revenue is Rs. 1173.00 Cr. and Equity Capital is Rs. 4.16 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Agro Chemicals/Pesticides	1501, Vikram Tower, Rajendra Place, New Delhi Delhi 110008	investors.brl@bharatgroup.co.in http://www.bharatgroup.co.in

Management
Name	Position Held
Mr. Sat Narain Gupta	Chairman & Managing Director
Mr. Mahabir Prasad Gupta	Whole Time Director
Mr. Rajender Prasad Gupta	WholeTime Director & CEO
Mr. Ajay Gupta	Executive Director
Mr. Kamleshwar Prasad Uniyal	Executive Director
Mrs. Sujata Agarwal	Ind. Non-Executive Director
Mr. Suresh Kumar Garg	Ind. Non-Executive Director
Mr. Ankit Aggarwal	Ind. Non-Executive Director
Ms. Mukta Gupta	Ind. Non-Executive Director
Mr. Rajesh Gupta	Ind. Non-Executive Director
Mr. Naman Jain	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Bharat Rasayan Ltd?

Bharat Rasayan Ltd's intrinsic value (as of 18 July 2025) is 9663.64 14.63% lower the current market price of 11,320.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,712 Cr. market cap, FY2025-2026 high/low of 14,284/8,798, reserves of 1,126 Cr, and liabilities of 1,408 Cr.

What is the Market Cap of Bharat Rasayan Ltd?

The Market Cap of Bharat Rasayan Ltd is 4,712 Cr..

What is the current Stock Price of Bharat Rasayan Ltd as on 18 July 2025?

The current stock price of Bharat Rasayan Ltd as on 18 July 2025 is 11,320.

What is the High / Low of Bharat Rasayan Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Bharat Rasayan Ltd stocks is ₹14,284/8,798.

What is the Stock P/E of Bharat Rasayan Ltd?

The Stock P/E of Bharat Rasayan Ltd is 33.4.

What is the Book Value of Bharat Rasayan Ltd?

The Book Value of Bharat Rasayan Ltd is 2,719.

What is the Dividend Yield of Bharat Rasayan Ltd?

The Dividend Yield of Bharat Rasayan Ltd is 0.01 %.

What is the ROCE of Bharat Rasayan Ltd?

The ROCE of Bharat Rasayan Ltd is 16.6 %.

What is the ROE of Bharat Rasayan Ltd?

The ROE of Bharat Rasayan Ltd is 13.3 %.

What is the Face Value of Bharat Rasayan Ltd?

The Face Value of Bharat Rasayan Ltd is 10.0.